Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bacampicillin and the immune response.

A Scordamaglia, G Ciprandi, S Mirabelli

    The Journal of Antimicrobial Chemotherapy
    |June 1, 1987
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Clinical use of biomarkers in breast cancer: Updated guidelines from the European Group on Tumor Markers (EGTM).

    European journal of cancer (Oxford, England : 1990)·2017
    Same author

    Outcome of EGFR inhibitors treatment in advanced NSCLC patients, not enrolled in clinical trials.

    Neoplasma·2017
    Same author

    A rare adverse reaction to ethambutol: drug-induced haemolytic anaemia.

    The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2016
    Same author

    Effectiveness and safety of mouthpiece ventilation and nocturnal non-invasive ventilation in patients with kyphoscoliosis: Short and long-term outcomes after an episode of acute respiratory failure.

    Revista portuguesa de pneumologia·2016
    Same author

    Efficacy of non-invasive ventilation for hypercapnic acute respiratory failure in a general ward: details and comments.

    Internal medicine journal·2015
    Same author

    Safety of vitamin K antagonist treatment for splanchnic vein thrombosis: a multicenter cohort study.

    Journal of thrombosis and haemostasis : JTH·2015
    Same journal

    Favipiravir tissue distribution and inhibitory quotients in preclinical models: towards a pipeline for evidence-based antiviral repurposing.

    The Journal of antimicrobial chemotherapy·2026
    Same journal

    A review of the randomized clinical trial results from the Staphylococcus aureus network adaptive platform (SNAP) meticillin-susceptible (MSSA) and penicillin-susceptible (PSSA) domains and CloCeBa.

    The Journal of antimicrobial chemotherapy·2026
    Same journal

    Incidence and factors associated with subtherapeutic cefazolin levels among patients with severe infections.

    The Journal of antimicrobial chemotherapy·2026
    Same journal

    Emerging resistance in staphylococci following long-term dalbavancin treatment for prosthetic joint infections.

    The Journal of antimicrobial chemotherapy·2026
    Same journal

    Microbiology testing around the time of antibiotic initiation among residents of long-term care facilities.

    The Journal of antimicrobial chemotherapy·2026
    Same journal

    Insights into the mechanisms underlying cell wall-active agents and gentamicin bactericidal synergism against Enterococcus faecalis.

    The Journal of antimicrobial chemotherapy·2026
    See all related articles

    Bacampicillin treatment for bacterial respiratory infections did not significantly impact immune function in patients. The antibiotic demonstrated clinical efficacy with no observed adverse effects on immune response, liver, or kidney function.

    Area of Science:

    • Immunology
    • Pharmacology
    • Infectious Diseases

    Background:

    • Bacterial respiratory tract infections are common and require effective antibiotic treatment.
    • Understanding the potential impact of antibiotics on the immune system is crucial for patient safety and treatment outcomes.

    Purpose of the Study:

    • To assess the influence of bacampicillin on various immune function parameters in patients with bacterial respiratory tract infections.
    • To evaluate the clinical efficacy and safety of bacampicillin in this patient population.

    Main Methods:

    • 16 patients with bacterial respiratory tract infections underwent immune function tests before and after bacampicillin treatment.
    • Tests included peripheral mononuclear blastogenic index, interferon-gamma production, T and B lymphocyte percentages, and serum immunoglobulin levels (IgG, IgM, IgA).

    Related Experiment Videos

  • Interleukin-2 production was also measured, and clinical condition, side-effects, and liver/kidney function were monitored.

    • Main Results:

    • No significant differences were observed in the blastogenic index, interferon-gamma, T and B lymphocyte percentages, or immunoglobulin levels post-treatment.
    • A trend towards increased interleukin-2 production was noted, but it did not reach statistical significance.
    • Clinical improvement was observed in 93.3% of patients, with no reported side-effects or alterations in liver or kidney function.

    Conclusions:

    • Bacampicillin does not appear to exert an inhibitory effect on the immune response.
    • The study confirms the clinical efficacy and safety of bacampicillin for treating bacterial respiratory tract infections.